SXTP — 60 Degrees Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- $4.36m
- $10.66m
- $1.41m
U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, NVIDIA
Brief: 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract
NASDAQ RESUMED AT 10:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM
Brief: 60 Degrees Pharmaceuticals Company Regained Compliance With Nasdaq Minimum Bid Price
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: 60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio
Brief: 60 Degrees Pharmaceuticals Announces Expansion Of Arakoda Sales And Marketing In 2026
Brief: 60 Degrees Pharmaceuticals Announces Clinical Site Now Open For Patient Enrollment
60 Degrees Pharma Q3 net product revenue rises
U.S. STOCKS ON THE MOVE-Bank of America, Dollar Tree, Morgan Stanley
U.S. STOCKS ON THE MOVE-Prologis, Winmark, Amphenol
U.S. STOCKS ON THE MOVE-Nvidia, First Horizon, 60 Degrees
60 Degrees jumps after first patient in tick-borne illness trial clears infection
Brief: 60 Degrees Pharmaceuticals Announces Closing Of Up To $10 Million Public Offering